Activation of the Monocyte/Macrophage System and Abnormal Blood Levels of Lymphocyte Subpopulations in Individuals with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

Autism spectrum disorder (ASD) is a neurodevelopmental condition with a so far unknown etiology. Increasing evidence suggests that a state of systemic low-grade inflammation may be involved in the pathophysiology of this condition. However, studies investigating peripheral blood levels of immune cells, and/or of immune cell activation markers such as neopterin are lacking and have provided mixed findings. We performed a systematic review and meta-analysis of studies comparing total and differential white blood cell (WBC) counts, blood levels of lymphocyte subpopulations and of neopterin between individuals with ASD and typically developing (TD) controls (PROSPERO registration number: CRD CRD42019146472). Online searches covered publications from 1 January 1994 until 1 March 2022. Out of 1170 publication records identified, 25 studies were finally included. Random-effects meta-analyses were carried out, and sensitivity analyses were performed to control for potential moderators. Results: Individuals with ASD showed a significantly higher WBC count (k = 10, g = 0.29, p = 0.001, I2 = 34%), significantly higher levels of neutrophils (k = 6, g = 0.29, p = 0.005, I2 = 31%), monocytes (k = 11, g = 0.35, p < 0.001, I2 = 54%), NK cells (k = 7, g = 0.36, p = 0.037, I2 = 67%), Tc cells (k = 4, g = 0.73, p = 0.021, I2 = 82%), and a significantly lower Th/Tc cells ratio (k = 3, g = −0.42, p = 0.008, I2 = 0%), compared to TD controls. Subjects with ASD were also characterized by a significantly higher neutrophil-to-lymphocyte ratio (NLR) (k = 4, g = 0.69, p = 0.040, I2 = 90%), and significantly higher neopterin levels (k = 3, g = 1.16, p = 0.001, I2 = 97%) compared to TD controls. No significant differences were found with respect to the levels of lymphocytes, B cells, Th cells, Treg cells, and Th17 cells. Sensitivity analysis suggested that the findings for monocyte and neutrophil levels were robust, and independent of other factors, such as medication status, diagnostic criteria applied, and/or the difference in age or sex between subjects with ASD and TD controls. Taken together, our findings suggest the existence of a chronically (and systemically) activated inflammatory response system in, at least, a subgroup of individuals with ASD. This might have not only diagnostic, but also, therapeutic implications. However, larger longitudinal studies including more homogeneous samples and laboratory assessment methods and recording potential confounding factors such as body mass index, or the presence of comorbid psychiatric and/or medical conditions are urgently needed to confirm the findings.

[1]  M. Simone,et al.  B and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder , 2021, Frontiers in Neuroscience.

[2]  Guohua Li,et al.  Risk of Self-harm in Children and Adults With Autism Spectrum Disorder , 2021, JAMA network open.

[3]  A. Tufan,et al.  Evaluation of peripheral inflammatory markers, serum B12, folate, ferritin levels and clinical correlations in children with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) , 2021, Nordic journal of psychiatry.

[4]  B. Aouizerate,et al.  Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates , 2021, Brain, Behavior, and Immunity.

[5]  M. Alpay,et al.  The systemic cell apoptotic-based neutrophil–lymphocyte ratio: Experience in children diagnosed with ADHD and Autism Spectrum Disorder , 2020, Konuralp Tıp Dergisi.

[6]  M. Ceylan,et al.  Serum Ischemia-Modified Albumin Levels, Myeloperoxidase Activity and Peripheral Blood Mononuclear cells in Autism Spectrum Disorder (ASD) , 2020, Journal of Autism and Developmental Disorders.

[7]  C. Nemeroff,et al.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble , 2020, Neuron.

[8]  M. Shehata,et al.  Thioredoxin level and inflammatory markers in children with autism spectrum disorders , 2020, Middle East Current Psychiatry.

[9]  P. Ashwood,et al.  T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms. , 2020, Brain, behavior, & immunity - health.

[10]  Mai Moaaz,et al.  Th17/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-β) in children with autism spectrum disorder , 2019, Journal of Neuroimmunology.

[11]  Matthew P. Anderson,et al.  T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains , 2019, Annals of neurology.

[12]  N. Rezaei,et al.  Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis. , 2019, Cytokine.

[13]  R. Frye,et al.  Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD) , 2019, Front. Psychiatry.

[14]  N. Rezaei,et al.  A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. , 2019, Journal of psychiatric research.

[15]  S. Wueest,et al.  The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release , 2018, Adipocyte.

[16]  R. Delorme,et al.  HLA-class II haplotypes and Autism Spectrum Disorders , 2018, Scientific reports.

[17]  B. H. Lo,et al.  Autism Spectrum Disorder , 2018, Journal of paediatrics and child health.

[18]  M. Zaki,et al.  Altered Adaptive Cellular Immune Function in a Group of Egyptian Children with Autism , 2017 .

[19]  M. Ceylan,et al.  High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders , 2017, International journal of developmental disabilities.

[20]  I. Frazer,et al.  Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.

[21]  E. Courchesne,et al.  Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder , 2017, Molecular Psychiatry.

[22]  F. Shebl,et al.  Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study , 2017, Molecular Autism.

[23]  A. Nadeem,et al.  Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism , 2016, Molecular Neurobiology.

[24]  M. Posada,et al.  Characterization of immune cell phenotypes in adults with autism spectrum disorders , 2016, Journal of Investigative Medicine.

[25]  E. Bosmans,et al.  Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder. , 2016, In vivo.

[26]  C. Tufanaru,et al.  Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness , 2015, International journal of evidence-based healthcare.

[27]  L. Barcellos,et al.  Immune mediated conditions in autism spectrum disorders , 2015, Brain, Behavior, and Immunity.

[28]  Jin-gang Fan,et al.  High plasma neopterin levels in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.

[29]  N. Kounis,et al.  White Blood Cell Counts, Leukocyte Ratios, and Eosinophils as Inflammatory Markers in Patients With Coronary Artery Disease , 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[30]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[31]  A. Guastella,et al.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis , 2014, Molecular Psychiatry.

[32]  I. Hertz-Picciotto,et al.  Maternal lifestyle and environmental risk factors for autism spectrum disorders. , 2014, International journal of epidemiology.

[33]  M. Ceylan,et al.  Serum neopterin levels in patients with autism , 2014 .

[34]  P. Ashwood,et al.  Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction , 2012, Journal of Neuroimmunology.

[35]  Jolanta Wasilewska,et al.  Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old , 2012, Archives of medical science : AMS.

[36]  T. Wilt,et al.  Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. , 2011, Journal of clinical epidemiology.

[37]  F. Shi,et al.  Organ-specific features of natural killer cells , 2011, Nature Reviews Immunology.

[38]  D. Amaral,et al.  In Search of Cellular Immunophenotypes in the Blood of Children with Autism , 2011, PloS one.

[39]  E. Courchesne,et al.  Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism , 2010, Biological Psychiatry.

[40]  P. Ashwood,et al.  Immune dysfunction in autism: A pathway to treatment , 2010, Neurotherapeutics.

[41]  G. Mostafa,et al.  Frequency of CD4+CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children With Autism , 2010, Journal of child neurology.

[42]  R. Drexhage,et al.  The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder , 2010, Expert review of neurotherapeutics.

[43]  Paula Krakowiak,et al.  Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders , 2009, Journal of Neuroimmunology.

[44]  C. Tinelli,et al.  An Autistic Endophenotype Results in Complex Immune Dysfunction in Healthy Siblings of Autistic Children , 2009, Biological Psychiatry.

[45]  J. Carcillo,et al.  Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[46]  J. Gregg,et al.  Altered gene expression and function of peripheral blood natural killer cells in children with autism , 2009, Brain, Behavior, and Immunity.

[47]  Jaquelyn B. McCandless,et al.  Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15 , 2008, Journal of Neuroimmunology.

[48]  David Moher,et al.  Addressing Reporting Biases , 2008 .

[49]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[50]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[51]  C. McDougle,et al.  High blood monocyte counts and neopterin levels in children with autistic disorder. , 2003, The American journal of psychiatry.

[52]  D. Fuchs,et al.  Neopterin as a marker for immune system activation. , 2002, Current drug metabolism.

[53]  K. Żwirska-Korczala,et al.  Neopterin measurement in clinical diagnosis , 2001, Journal of clinical pharmacy and therapeutics.

[54]  R. Warren,et al.  Reduced natural killer cell activity in autism. , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.

[55]  A. Kutlu,et al.  Does increased neutrophil-lymphocyte ratio predict autism spectrum disorder? , 2018 .

[56]  I. Tonhajzerova,et al.  Inflammatory Activity in Autism Spectrum Disorder. , 2015, Advances in experimental medicine and biology.

[57]  J. Higgins Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[58]  Karen Shashok,et al.  BMC Medical Research Methodology BioMed Central Debate Conducting a meta-ethnography of qualitative literature: Lessons learnt , 2008 .

[59]  C. Tirolo,et al.  Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. , 1996, Annali dell'Istituto superiore di sanita.